kneat.com (KSI) Aktienübersicht
kneat.com, inc. entwirft, entwickelt und liefert zusammen mit seinen Tochtergesellschaften Software für das Daten- und Dokumentenmanagement in regulierten Umgebungen in Nordamerika, Europa und dem asiatisch-pazifischen Raum. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 0/6 |
KSI Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
kneat.com, inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | CA$6.48 |
| 52-Wochen-Hoch | CA$6.50 |
| 52-Wochen-Tief | CA$3.23 |
| Beta | 1.35 |
| 1 Monat Veränderung | 0.31% |
| 3 Monate Veränderung | 48.28% |
| 1 Jahr Veränderung | 13.29% |
| 3 Jahre Veränderung | 101.24% |
| 5 Jahre Veränderung | 110.39% |
| Veränderung seit IPO | 1,751.43% |
Aktuelle Nachrichten und Updates
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.Recent updates
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.KSI: Global Pharma Agreements And Data Integrity Adoption Will Support Future Margin Expansion
Analysts have trimmed their average price target on kneat.com to CA$5.50 from CA$6.50, citing refreshed assumptions around discount rates, long term growth expectations and valuation multiples, while generally maintaining positive ratings on the shares. Analyst Commentary Recent research on kneat.com points to a reset in expectations, with price targets grouped around CA$5.50 and ratings that remain generally constructive on the company’s execution and growth potential.KSI: Data Integrity Adoption And New Pharma Wins Will Support Future Margin Expansion
The analyst price target for kneat.com has been trimmed to CA$5.50 from CA$6.50. Analysts are factoring in an updated fair value of CA$5.70, a modestly higher discount rate, and adjusted revenue growth and profit margin assumptions, while still citing generally positive research commentary on the shares.KSI: Data Integrity Adoption Will Support Future Margin Expansion Despite Reset Expectations
Analysts have reduced their fair value estimate for kneat.com to CA$5.75 from CA$6.67. This change reflects recent cuts to Street price targets to around CA$5.50 and more cautious assumptions on growth, margins, and future P/E.KSI: Data Integrity Adoption Will Support Future Margin Expansion Potential
Analysts have maintained their CA$6.67 price target on kneat.com, citing supportive TD Securities research. The research highlights the company’s growth profile and long-term margin potential, as reflected in modest adjustments to the discount rate, revenue growth, and future P/E assumptions.KSI: Global Validation Wins And Bullish Coverage Will Support Future Upside
Analysts have trimmed their price expectations for kneat.com, with recent targets moving from C$7.50 to C$5.50 and from C$8.50 to C$7.50. This reflects updated views on fair value, profitability assumptions and future P/E levels, while a new bullish initiation from TD Securities highlights ongoing interest in the name.KSI: Global Validation Agreements Will Support Future Upside Despite Lowered Street Expectations
Narrative update on kneat.com The analyst price target for kneat.com has been revised lower to C$5.50 to C$7.50, down from C$7.50 to C$8.50, as analysts adjust their views while maintaining positive ratings on the shares. Analyst Commentary Recent research reflects a mixed but generally constructive stance on kneat.com, with both supporting and cautionary points tied to the revised price targets of C$5.50 and C$7.50 and the maintained positive ratings.KSI: Global Validation Agreements Will Support Future Upside Despite Recent Estimate Revisions
Analysts nudged their fair value estimate for kneat.com to C$6.80 from C$6.60. Recent Street price target updates to C$5.50 and C$7.50 helped frame the new outlook on discount rates, revenue growth, profit margins and future P/E assumptions.KSI: Expanding Global Validation Agreements Will Drive Future Outperformance
We lower our Kneat.com price target to C$5.50 from C$7.50, reflecting analysts' reduced near term expectations for valuation multiples, despite largely unchanged long term growth and margin assumptions. Analyst Commentary Recent Street research reflects a more tempered near term outlook for Kneat.com, with price targets revised lower but positive ratings maintained, signaling continued confidence in the company’s underlying growth trajectory.KSI: Expansion Of Global Customer Agreements Will Drive Outperformance Ahead
Analysts have reduced their average price target for kneat.com from $6.80 to $6.60. This change is attributed to recent downward revisions to growth and profit forecasts.Market Cool On kneat.com, inc.'s (TSE:KSI) Revenues Pushing Shares 26% Lower
The kneat.com, inc. ( TSE:KSI ) share price has fared very poorly over the last month, falling by a substantial 26...KSI: Momentum In Securing New Customers Will Drive Performance Ahead
Analysts have lowered their price targets for kneat.com. Target estimates have decreased from C$8.50 and C$7.50 previously to updated levels of C$7.50 and C$5.50 respectively, citing slower expected revenue growth and a slightly higher discount rate as key factors in their revised outlook.
Life Sciences Wins And Expanded Sales Will Open Future Markets
Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins.kneat.com, inc. (TSE:KSI) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for kneat.com, inc. ( TSE:KSI ) shareholders, with its shares surging 15% to CA$6.88 in...A Look At The Intrinsic Value Of kneat.com, inc. (TSE:KSI)
Key Insights The projected fair value for kneat.com is CA$5.19 based on 2 Stage Free Cash Flow to Equity Current share...Investors Still Waiting For A Pull Back In kneat.com, inc. (TSE:KSI)
With a price-to-sales (or "P/S") ratio of 10.1x kneat.com, inc. ( TSE:KSI ) may be sending very bearish signals at the...Is kneat.com (TSE:KSI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Here's Why We're Not Too Worried About kneat.com's (TSE:KSI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Fewer Investors Than Expected Jumping On kneat.com, inc. (TSE:KSI)
There wouldn't be many who think kneat.com, inc.'s ( TSE:KSI ) price-to-sales (or "P/S") ratio of 8.7x is worth a...Aktionärsrenditen
| KSI | CA Healthcare Services | CA Markt | |
|---|---|---|---|
| 7D | 0.3% | -4.1% | 0.6% |
| 1Y | 13.3% | -14.8% | 28.2% |
Rendite im Vergleich zur Industrie: KSI übertraf die Branche Canadian Healthcare Services , die im vergangenen Jahr eine Rendite von -14.8 erzielte.
Rendite vs. Markt: KSI hinter dem Markt Canadian zurück, der im vergangenen Jahr eine Rendite von 28.2 erzielte.
Preisvolatilität
| KSI volatility | |
|---|---|
| KSI Average Weekly Movement | 6.6% |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in CA Market | 16.5% |
| 10% least volatile stocks in CA Market | 3.7% |
Stabiler Aktienkurs: KSI hatte in den letzten 3 Monaten im Vergleich zum Canadian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: KSIDie wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2007 | 343 | Eddie Ryan | kneat.com |
kneat.com, inc. entwirft, entwickelt und liefert zusammen mit seinen Tochtergesellschaften Software für das Daten- und Dokumentenmanagement in regulierten Umgebungen in Nordamerika, Europa und dem asiatisch-pazifischen Raum. Das Unternehmen bietet die Kneat Gx Plattform an, eine konfigurierbare Standardanwendung, die sich auf das Management des Validierungslebenszyklus und die Prüfung für die Biotechnologie-, Pharma- und Medizinprodukteindustrie konzentriert. Die Plattform wird in verschiedenen Anwendungen eingesetzt, darunter Dokumentenmanagement, Validierung von Analyseinstrumenten, Methodenvalidierung, Inbetriebnahme und Qualifizierung, Zeichnungsverwaltung, Validierung von Versorgungseinrichtungen und Anlagen, Kühlkettenvalidierung, elektronisches Logbuchmanagement, Prozessvalidierung, Validierung von Computersystemen und Reinigungsvalidierung.
kneat.com, inc.'s Grundlagenzusammenfassung
| KSI grundlegende Statistiken | |
|---|---|
| Marktanteil | CA$625.46m |
| Gewinn(TTM) | -CA$8.44m |
| Umsatz(TTM) | CA$66.52m |
Ist KSI zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| KSI Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | CA$66.52m |
| Kosten der Einnahmen | CA$15.54m |
| Bruttogewinn | CA$50.97m |
| Sonstige Ausgaben | CA$59.41m |
| Gewinn | -CA$8.44m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -0.088 |
| Bruttomarge | 76.63% |
| Nettogewinnspanne | -12.69% |
| Schulden/Eigenkapital-Verhältnis | 31.6% |
Wie hat sich KSI auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/27 22:27 |
| Aktienkurs zum Tagesende | 2026/07/27 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
kneat.com, inc. wird von 9 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Gavin Fairweather | ATB Cormark |
| Douglas Taylor | Canaccord Genuity |
| Stephanie Price | CIBC Capital Markets |